Wednesday, August 10, 2016 7:21:01 AM
Not much equity in the property given mortgage is due[ by iclight post 67641
When is her presentation, "How to pay your mortgage with no money"? by iclight post 65875
Funny, but there is an issue in play here. Of course they could just default and let the property revert to that company LP set up to get the deal done by exwannabe post 65877
iclight Tuesday, 07/05/16 03:50:05 PM
Re: beartrap12 post# 66019
Post #
66034 of 69122 Go
Cognate has a Memphis plant. NWBO can't afford to pay for them to produce now. NWBO owns Sawston which obviously can't supply for commercialization because they might not own it after they default on the mortgage and they don't have cash to clean up the toxic issues. Kings College hasn't made a vaccine for anyone in England (Those are made at Fraunhofer) and Germany won't accept vaccines produced outside of Germany for HE anyway. That's if they were able to pay Fraunhofer per the contract even though they didn't have to produce many vaccines at all during the halt.
All of NW's money for expansion and production hasn't bought much, has it?
foxhound02 Wednesday, 07/13/16 09:14:27 PM
Re: None
Post # 66796 of 69124 Go
Anyone want to make guesses as to how long it will be until the company goes bankrupt? I give it two weeks. The company and all intellectual property will go to Cognate. The last raise should cover paying the utilities. Anyone owning shares will be wiped out. Still have 10 shares dating back 15 years (can't remember)?? It was a round-off from the reverse split forever ago.
When is her presentation, "How to pay your mortgage with no money"? by iclight post 65875
Funny, but there is an issue in play here. Of course they could just default and let the property revert to that company LP set up to get the deal done by exwannabe post 65877
iclight Tuesday, 07/05/16 03:50:05 PM
Re: beartrap12 post# 66019
Post #
66034 of 69122 Go
Cognate has a Memphis plant. NWBO can't afford to pay for them to produce now. NWBO owns Sawston which obviously can't supply for commercialization because they might not own it after they default on the mortgage and they don't have cash to clean up the toxic issues. Kings College hasn't made a vaccine for anyone in England (Those are made at Fraunhofer) and Germany won't accept vaccines produced outside of Germany for HE anyway. That's if they were able to pay Fraunhofer per the contract even though they didn't have to produce many vaccines at all during the halt.
All of NW's money for expansion and production hasn't bought much, has it?
foxhound02 Wednesday, 07/13/16 09:14:27 PM
Re: None
Post # 66796 of 69124 Go
Anyone want to make guesses as to how long it will be until the company goes bankrupt? I give it two weeks. The company and all intellectual property will go to Cognate. The last raise should cover paying the utilities. Anyone owning shares will be wiped out. Still have 10 shares dating back 15 years (can't remember)?? It was a round-off from the reverse split forever ago.
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
